Hints and tips:
...“He has the most encyclopedic memory of deals, products and companies and can pull examples and learn from them,” said former colleague Alexander Hardy, chief executive of US biotech group BioMarin....
...AG: I think that’s very accurate. The technology ambition was immense and the technology capacity, in terms of talent in compute, was immense. The product ambition . . . was absent....
...It is grappling with total debt estimated at about €42bn, one of the biggest product liability cases in corporate history, plus a pharmaceuticals growth problem....
...The New York-based securitised products business packaged debts, such as mortgages and loans for yachts, before selling them on as securities....
...from the fallout of its ill-fated $63bn takeover of US seeds-maker Monsanto in 2016, which saddled the company with billions in debt and exposed it to costly litigation over Roundup....
...The German conglomerate maintains that the product is safe and says scientific research supports that view....
...About 60 per cent of world sales are generic products, most of which are made in China. Anderson will hopefully substitute signal for noise when he presents earnings on August 8....
...Bayer said it would appeal against the verdicts and accused plaintiffs of having misrepresented “worldwide regulatory and scientific support for our products” in court, adding that it had “strong arguments...
...Bayer has denied the product causes cancer. “We’re not happy with this year’s performance,” Anderson told reporters on Wednesday after Bayer reported third-quarter results....
...Products are complementary, meaning they can be cross-sold to the two groups’ existing customer base....
...The company is still reeling from its ill-fated $63bn takeover of the US seeds maker Monsanto in 2016....
...Anderson is also facing new concerns over the Roundup litigation, one of the biggest product liability cases in corporate history....
...This was implemented this year and the product is still named Roundup. Bayer has employed some unusual tactics as it continues to fight the cases....
...As well as investing clients’ money heavily into hard-to-sell investment products brokered by Greensill, Haywood was a go-between in GAM’s negotiations of side deals with the firm’s Australian founder Lex...
...They produce prescription drugs against cancer, heart disease and other illness, over-the-counter healthcare products like Bepanthen cream as well as seeds and herbicides for farmers....
...Bayer has had to absorb billions in litigation costs following Baumann’s ill-fated 2016 acquisition of US agrichemical group Monsanto....
...Bayer maintains that the product is safe....
...Bayer maintains the product, whose main ingredient is glyphosate, is safe and says scientific research supports that view....
...The firm gained the upper hand earlier this month in a takeover battle for Software AG, one of the largest and oldest technology companies in Europe....
...two businesses complement one another, with UBS Asset Management more focused on active strategies designed for its wealthy clients, while the Credit Suisse business has a higher proportion of passive products...
...Sales in Bayer’s pharmaceuticals operations were helped by new products. The business is fighting market fears that the expiry of patent protection on important products will depress profits....
...It has been hit hard by litigation involving Roundup — a weedkiller it acquired when it bought Monsanto — claiming that the herbicide caused cancers....
...More than six years on from Bayer’s poorly timed decision to acquire America’s Monsanto, the latter’s litigation woes about weedkiller Roundup still weigh on Bayer’s share price....
...The success of Bayer’s US pharma unit stands in contrast to the company’s disastrous $63bn takeover of Monsanto in 2018, which has cost it $16bn in legal settlements so far linked to claims that its weed...
...The New York-based securitised products business packages debts, such as mortgages and loans for yachts, before selling them on as securities....
International Edition